Navigation Links
Herr receives Heinz Award for Technology, the Economy and Employment

PITTSBURGH, September 12, 2007 A double amputee whose trailblazing work in the emerging field of biomechatronics has led to the development of new prosthetic innovations that merge body and machine has been selected to receive the 13th annual Heinz Award for Technology, the Economy and Employment, among the largest individual achievement prizes in the world.

Dr. Hugh Herr, 43, a professor at the Massachusetts Institute of Technologys Media Lab whose advances in prosthetics and orthotics technology that marries robotics and human biomechanics have given greater mobility and new hope to those with physical disabilities, is among six distinguished Americans selected to receive one of the $250,000 awards, presented in five categories by the Heinz Family Foundation.

Everything about Dr. Herr is an expression of the triumph of the human spirit over adversity, said Teresa Heinz, chairman of the Heinz Family Foundation. His breakthrough advances in rehabilitation technologies are immeasurably improving the quality of life for thousands of people with physical challenges, but for him, every breakthrough is just an invitation to push harder and do more. Accomplished yet modest, determined yet good natured, he approaches his work with great skill and great wonder. Both his life and his inventions demonstrate what an unbeatable combination that is.

With more than 36,000 new amputees in the United States every year including hundreds of American soldiers who have lost limbs in the War in Iraq and Afghanistan since 2001 Dr. Herr is helping improve mobility and enhance the quality of life for many physically challenged people around the world. The holder (or co-holder) of numerous patents, including the Computer-Controlled Artificial Knee (commercially available as the Rheo Knee), the Active Ankle-Foot Orthosis, and the worlds first Powered Ankle-Foot Prosthesis, he is advancing an emerging field of science that applies the principles of muscle mechanics, neural control and human biomechanics to guide the design of biomimetic robots, human rehabilitation devices and other technologies.

Most recently, Dr. Herr and his Biomechatronics research group at the MIT Media Lab have developed a robotic foot-ankle prosthesis capable of propelling the wearer forward and varying its stiffness over irregular terrain, successfully mimicking the action of a biological angle, and, for the first time, providing amputees with a truly humanlike gait. This new ankle is light, flexible and most importantly generates energy for walking beyond that which can be released from a spring alone. It mimics the elegance of nature, explains Dr. Herr, where muscle-like robotic assist releases three times the power of conventional prostheses to propel the body upward and forward in walking.

At age 17, Dr. Herr lost both legs below the knee in a mountain climbing accident, but returned to the classroom after a few years to earn an undergraduate degree in physics, a masters degree in mechanical engineering from MIT and a Ph.D. in biophysics from Harvard. Today, his work at the MIT Media Lab focuses on human amplification and rehabilitation systems technologies that interact with human limbs, mimicking biological performance and amplifying function. While there was a time when leg prostheses hampered a wearers mobility, Dr. Herrs breakthrough innovations are enabling leg amputees to walk at higher speeds with greater stability and lower metabolic energy. He predicts that in five to 10 years, leg amputees will be able to run faster and move with a lower metabolic rate than people with biological limbs.

Given the high number of U.S. soldiers returning home with crippling injuries, the Department of Veterans Affairs (VA) is funding a $7.2 million research project being conducted by the Center for Restorative and Regenerative Medicine, a collaboration among MIT, Brown University and the Providence, Rhode Island VA Medical Center. The effort focuses on developing new technologies for amputees, specifically biohybrid limbs comprised of regenerated tissue, lengthened bone, titanium bone implants, implantable neural sensors and external robotic limbs.

The subject of a Discovery Channel movie in 2002, Dr. Herr is very involved in sporting activities, including No Barriers USA, which promotes the advancement of new technologies and techniques to improve the quality of life of physically challenged people.

The nature of my work has been incredibly gratifying, not only by virtue of the impact it has on those of us with physical challenges, but also for its potential impact on the larger population as a whole, Dr. Herr said. This field is still in its infancy, and I have great hope that it can be applied to a broad range of utility to make healthy bodies better and stronger, to create new forms of mobility and to expand our capacity to perform beyond human limits. My thanks go out to the Heinz Family Foundation for recognizing me and by extension my many colleagues over the years with this magnificent honor.

Since 1993, the Heinz Family Foundation of Pittsburgh has recognized individuals whose dedication, skill and generosity of spirit represent the best of the human qualities that the late Sen. Heinz, for whom the award is named, held so dear.

Presented in five categories, the other Heinz Award recipients are:

  • Arts and Humanities: Dave Eggers, San Francisco, author and founder of the 826 Valencia writing laboratories as well as a publishing house for emerging writers
  • Environment (co-recipients): Bernard Amadei, Ph.D., Boulder, Colo., engineer, professor and founder of Engineers without Borders - USA; and Susan Seacrest, Lincoln, Neb., environmental advocate and founder of the Groundwater Foundation
  • Human Condition: David L. Heymann, M.D., Geneva, Switzerland, physician, an assistant director general of the World Health Organization and international public health advocate
  • Public Policy: Donald M. Berwick, M.D., Cambridge, Mass., physician, professor and health care reformer


Contact: Jon Newman
The Heinz Family Foundation

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
6. NJIT Presidential Award winner takes stem cell research another step
7. TGen awarded $7.1 million to accelerate brain disease research
8. Virtual microscopy project wins educational technology award
9. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
10. Long-lived deep-sea fishes imperiled by technology, overfishing
Post Your Comments:
(Date:2/3/2017)... , Feb. 3, 2017  Texas Biomedical Research Institute ... Larry Schlesinger as the Institute,s new President ... Biomed effective May 31, 2017. He is currently the Chair ... of the Center for Microbial Interface Biology at Ohio State ... as the new President and CEO of Texas Biomed," said ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Financial Highlights (in ... Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$     ... Revenue 3539(10)%9498(4)%Kuvan Net Product Revenue ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
(Date:2/23/2017)... Minn. , Feb. 23, 2017  Imanis ... new product line of oncolytic vaccinia viruses for ... Corporation as part of Genelux,s proprietary, vaccinia virus-based ... are excited to enter into a partnership with ... selected oncolytic vaccinia viruses for use in research," ...
Breaking Biology Technology: